Managed Care Savings In USA May Be Coming To An End

26 March 1997

Many of the savings in health care costs achieved in the USA throughmanaged care and health maintenance organizations may be coming to an end, writes Lisa Bransten in the UK-based Financial Times. These have meant that instead of traditional health insurance just paying up for the medical services given, HMOs have monitored medical services and to some extent have dictated what services can be provided.

Currently, some 75% of working Americans are covered through HMOs or other managed care organizations. However, says Ms Bransten, health care providers (doctors, hospitals, etc) and consumers "are trying to reclaim some of the power they lost in that shift." Many doctors, she says, are joining forces to gain the bargaining power of managed care firms.

Meantime, a new study (Partnering for Value: the Second Annual Washington Business Group on Health/Watson Wyatt Worldwide Study on Value in Health Care) has noted that US companies are moving steadily toward value-based purchasing of health care.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight